X

About this post

Source
Author
Date
4:36 PM | December 13, 2012
Language
English
Categories
URL
Link to this page


There is no other way to say it. This year has been a terrible one for cleantech firms hoping to access the public markets to fund commercialization. Investors seem to be allergic to the very idea of owning stock in a cleantech firm. Cleantech Chemistry thinks that one might still squeak through before the end of [...]

Tags

Comments

Log in to leave a comment